PRGO
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Head of Investor Relations
PERRIGO Co plc (PRGO)Equibles does not estimate personal net worth.
Get an email with a short summary when PERRIGO Co plc publishes a filing, an earnings call transcript or a press release.
Get PRGO alertsBrad Joseph is recorded as Head of Investor Relations at PERRIGO Co plc (PRGO). Brad Joseph has spoken on 8 earnings calls across 1 company, most recently for PERRIGO Co plc on February 26, 2026. PERRIGO Co plc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at PERRIGO Co plc includes Albert A. Manzone (CEO and Board Member), Patrick Lockwood-Taylor (CEO), Eduardo Bezerra (CFO) and 7 others.
“I hope you all had a chance to review our release issued this morning. A copy of the earnings release and presentation for today’s discussion are available within the Investors section of perrigo.com website.”
“I hope you all had a chance to review our release issued this morning. A copy of the earnings release and presentation for today’s discussion are available within the Investors section of perrigo.com website.”
“Good morning, everyone, and welcome to Perrigo’s first quarter 2023 earnings conference call. I hope you all had a chance to review our release we issued this morning.”
“Good morning, everyone and welcome to Perrigo’s third quarter 2022 earnings conference call. I hope you all had a chance to review the earnings press release we issued this morning.”
PRGO
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations